Motrin (ibuprofen) is a nonsteroidal anti-inflammatory drug indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis, for relief of mild to moderate pain, and for treatment of primary dysmenorrhea. Side Effects of Meloxicam Almost all medicines may cause possible side-effects. A side effect is an unnecessary consequence of a medicine when it can be consumed in regular doses. Common side effects of Celebrex include diarrhea, indigestion, and abdominal pain. This page of the eMedTV Web site provides a list of side effects a person might experience while taking Celebrex. Most people, however, tolerate the drug quite well. Drug Information on Mobic, Vivlodex (meloxicam) includes drug pictures, side effects, drug interactions, directions for use, symptoms of overdose, and what to avoid. Meloxicam, sold under the brand name Mobic, is a prescription drug used to treat pain and inflammation. Meloxicam is prescribed to people who have tenderness, swelling, and pain caused by the. Find a comprehensive guide to possible side effects including common and rare side effects when taking Mobic (Meloxicam) for healthcare professionals and consumers. Mobic (meloxicam) is a nonsteroidal anti-inflammatory drug used to treat pain or inflammation caused by arthritis. Includes Mobic side effects, interactions and indications. Side Effects. Tooth/tongue staining, increased tartar, mouth/throat irritation, dry mouth, and change in taste of food/drinks may occur. If any of these effects persist or worsen, tell your doctor. Explains the medication meloxicam (Mobic), a drug used to treat tenderness, swelling and pain caused by the inflammation of osteoarthritis and rheumatoid arthritis. Side effects, drug interactions, dosing, storage, and pregnancy and breastfeeding safety information is provided. Along with its needed effects, meloxicam (the active ingredient contained in Mobic) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.